Breaking News Instant updates and real-time market news.

ELGX

Endologix

$6.73

-0.07 (-1.03%)

09:04
05/18/17
05/18
09:04
05/18/17
09:04

Endologix downgraded to Perform from Outperform at Oppenheimer

Oppenheimer analyst Steven Lichtman downgraded Endologix to Perform and lowered his price target for the shares to $5.50 from $10. The downgrade follows the company's announcement that it willseek U.S. approval of the Nellix EVAS System by conducting a confirmatory clinical study. BTIG and Stifel this morning also downgraded Endologix.

  • 18

    May

  • 31

    May

ELGX Endologix
$6.73

-0.07 (-1.03%)

05/17/17
STFL
05/17/17
DOWNGRADE
STFL
Hold
Endologix downgraded to Hold from Buy at Stifel
05/18/17
BTIG
05/18/17
DOWNGRADE
Target $7
BTIG
Neutral
Endologix downgraded to Neutral from Buy at BTIG
05/18/17
STFL
05/18/17
DOWNGRADE
STFL
Hold
Endologix downgraded on strategy change at Stifel
As noted earlier, Stifel downgraded Endologix to Hold from Buy. Analyst Mathew Blackman downgraded the stock after the company announced that after meeting with the FDA it will not seek approval of its first generation Nelix device and will instead seek approval of its second generation Nelix device. Blackman notes that an additional clinical trial will have to be performed on the second generation device before it can be approved. He does not expect it to be approved until 2020 at the earliest. Target to $5.50 from $10.
05/18/17
BTIG
05/18/17
DOWNGRADE
BTIG
Neutral
Endologix downgraded on new trial at BTIG
As noted earlier, BTIG downgraded Endologix to Neutral from Buy. Analyst Sean Lavin downgraded the stock after the company announced that following its meeting with the FDA it will not seek approval of its first generation Nelix device and will instead seek approval of its second generation Nelix device. Lavin notes that an additional clinical trial will have to be performed on the second generation device before it can be approved. He does not expect the device to reach the U.S. market until 2020. Target $7.

TODAY'S FREE FLY STORIES

EC

Ecopetrol

$9.36

-0.23 (-2.40%)

07:33
05/31/17
05/31
07:33
05/31/17
07:33
Downgrade
Ecopetrol rating change  »

Ecopetrol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNKN

Dunkin' Brands

$58.32

0.15 (0.26%)

07:32
05/31/17
05/31
07:32
05/31/17
07:32
Hot Stocks
Dunkin' Brands names Kate Jaspon as CFO, effective June 5 »

Dunkin' Brands Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

, UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Recommendations
Exact Sciences, UnitedHealth analyst commentary  »

Exact Sciences remains a…

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 06

    Jun

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

, NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 09

    Jun

FRO

Frontline

$5.41

-0.22 (-3.91%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Upgrade
Frontline rating change  »

Frontline upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGHT

8x8, Inc.

$13.60

0.1 (0.74%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Conference/Events
8x8, Inc. management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 06

    Jun

  • 08

    Jun

  • 13

    Jun

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

, FRO

Frontline

$5.41

-0.22 (-3.91%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Recommendations
Gener8 Maritime, Frontline, DHT Holdings analyst commentary  »

Gener8 Maritime advance…

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

FRO

Frontline

$5.41

-0.22 (-3.91%)

DHT

DHT Holdings

$4.20

-0.07 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

, ORCL

Oracle

$45.42

0.16 (0.35%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

ORCL

Oracle

$45.42

0.16 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:25
05/31/17
05/31
07:25
05/31/17
07:25
Technical Analysis
Technical View: Michael Kors drops to new 52-week low after earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CBS

CBS

$61.52

-0.05 (-0.08%)

, CBS.A

$63.50

-0.15 (-0.24%)

07:24
05/31/17
05/31
07:24
05/31/17
07:24
Periodicals
Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says »

CBS (CBS, CBS.A) news…

CBS

CBS

$61.52

-0.05 (-0.08%)

CBS.A

$63.50

-0.15 (-0.24%)

CMCSA

Comcast

$41.10

0.19 (0.46%)

CMCSK

Comcast

DIS

Disney

$108.34

-0.07 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 08

    Jun

  • 15

    Jun

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors drops 7% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

UAA

Under Armour

$19.56

-0.13 (-0.66%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Recommendations
Under Armour analyst commentary  »

Under Armour has reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

07:22
05/31/17
05/31
07:22
05/31/17
07:22
General news
Futures higher ahead of final trading for May »

Stock futures are above…

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:22
05/31/17
05/31
07:22
05/31/17
07:22
Hot Stocks
Michael Kors says to close 100-125 full-price retail stores over next two years »

Michael Kors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MYL

Mylan

$39.36

-0.36 (-0.91%)

07:19
05/31/17
05/31
07:19
05/31/17
07:19
Recommendations
Mylan analyst commentary  »

Pension fund campaign a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 09

    Oct

VIAB

Viacom

$35.05

-0.08 (-0.23%)

, VIA

Viacom

$38.90

0.5 (1.30%)

07:17
05/31/17
05/31
07:17
05/31/17
07:17
Recommendations
Viacom, Viacom analyst commentary  »

Viacom price target…

VIAB

Viacom

$35.05

-0.08 (-0.23%)

VIA

Viacom

$38.90

0.5 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$1.37

-0.02 (-1.44%)

07:17
05/31/17
05/31
07:17
05/31/17
07:17
Hot Stocks
22nd Century reports 'dramatic surge' in VLN tobacco clinical trials, science »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$45.00

0.29 (0.65%)

07:16
05/31/17
05/31
07:16
05/31/17
07:16
Recommendations
Abbott analyst commentary  »

Abbott making progress, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRMN

Garmin

$52.11

-0.29 (-0.55%)

07:15
05/31/17
05/31
07:15
05/31/17
07:15
Hot Stocks
Garmin launches Approach S60 golf watch »

Garmin International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCA

U.S. Silica

$36.45

-0.76 (-2.04%)

07:15
05/31/17
05/31
07:15
05/31/17
07:15
Technical Analysis
Technical View: U.S. Silica trades higher in pre-market »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GPRK

GeoPark

$8.71

-0.18 (-2.02%)

07:12
05/31/17
05/31
07:12
05/31/17
07:12
Hot Stocks
GeoPark names Coulter Enterprises Chairman and CEO Coulter to board »

GeoPark Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$4.70

-0.3 (-6.00%)

07:12
05/31/17
05/31
07:12
05/31/17
07:12
Hot Stocks
ProQR Therapeutics' QR-110 granted Fast Track designation by FDA »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$66.30

-0.57 (-0.85%)

07:11
05/31/17
05/31
07:11
05/31/17
07:11
Downgrade
Molina Healthcare rating change  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$43.41

0.74 (1.73%)

07:11
05/31/17
05/31
07:11
05/31/17
07:11
Technical Analysis
Technical View: GlaxoSmithKline rises in early trading »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

RGNX

Regenxbio

$16.70

-1.3 (-7.22%)

07:09
05/31/17
05/31
07:09
05/31/17
07:09
Earnings
Regenxbio initiates Phase 1 clinical trial of RGX-314 for macular degeneration »

Regenxbio has dosed the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.